About two-thirds of the global population under age 50 has HSV-1, the virus most commonly associated with cold sores. That translates to roughly 3.7 billion people worldwide. In the United States, the rate is lower but still substantial: about 48% of people aged 14 to 49 carry the virus, and the percentage climbs steadily with age.
Global Prevalence by Region
A 2016 World Health Organization analysis estimated that 66.6% of people aged 0 to 49 worldwide were infected with HSV-1. The vast majority of those infections are oral, with a global oral HSV-1 prevalence of 63.6%. A smaller but significant number, about 192 million people aged 15 to 49, carry HSV-1 as a genital infection.
Rates vary dramatically by region. Africa has the highest oral HSV-1 prevalence at roughly 88% for both men and women. The Americas have the lowest: about 38% in women and 32% in men. Europe falls in between, with a notable gap between women (61%) and men (40%). South-East Asia and the Western Pacific region both sit in the 62 to 75% range.
These regional differences largely reflect when people first encounter the virus during childhood. In countries where HSV-1 spreads early in life through household contact, prevalence is near-universal by adulthood. In higher-income countries where childhood exposure has decreased, more people reach adolescence and adulthood without prior infection, which paradoxically makes them vulnerable to acquiring HSV-1 genitally through sexual contact later on.
United States Rates by Age
CDC data from the 2015–2016 National Health and Nutrition Examination Survey (NHANES) found an overall HSV-1 prevalence of 47.8% among Americans aged 14 to 49. That number rises in a nearly straight line with each decade of life:
- Ages 14–19: 27.0%
- Ages 20–29: 41.3%
- Ages 30–39: 54.1%
- Ages 40–49: 59.7%
A broader meta-analysis that included older adults found the pattern continues: pooled seroprevalence reaches about 68% among people in their 40s and 88% among those 50 and older. So while “about half” is the commonly cited figure for working-age Americans, the lifetime likelihood of carrying HSV-1 is much higher.
Childhood Acquisition
Many people pick up HSV-1 as young children, typically through kisses or shared utensils with family members who carry the virus. In the U.S., roughly 32.5% of children under 10 already test positive for HSV-1 antibodies. By the teenage years, that figure rises to about 39.5%. In regions like Africa, childhood acquisition is nearly universal, which is why adult prevalence there exceeds 85%.
The trend in higher-income countries has been moving in the opposite direction. Smaller household sizes, improved hygiene, and less intergenerational contact mean fewer children encounter HSV-1 early. This sounds like good news, but it creates a growing population of young adults with no prior immunity, shifting the age of first infection from childhood to the sexually active years.
HSV-1 as a Genital Infection
HSV-1 is increasingly responsible for genital herpes, particularly in higher-income countries. Globally, about 5.2% of people aged 15 to 49 carry genital HSV-1. But the regional spread is telling. In the Americas, genital HSV-1 affects roughly 15 to 16% of adults, compared to just 0.1% in Africa. The pattern is essentially the inverse of oral HSV-1: where childhood oral infection is common, genital HSV-1 is rare, because people already have partial immunity by the time they become sexually active.
In Europe, genital HSV-1 prevalence runs about 11 to 17%, following a similar pattern. Genital HSV-1 infections tend to recur less frequently than genital HSV-2 infections, but the initial outbreak can be just as painful.
Most People Never Have Symptoms
The majority of people with HSV-1 don’t know they have it. Many were infected as children and never experienced a noticeable outbreak, or had symptoms mild enough to be mistaken for a chapped lip or canker sore. The virus establishes a permanent home in nerve cells and stays dormant most of the time.
Even without visible sores, the virus periodically reactivates and reaches the skin surface. This asymptomatic shedding occurs on roughly 3 to 28% of days in people who carry latent HSV-1, depending on the individual and the site of infection. During these episodes, the virus can be transmitted to others even though the carrier has no symptoms and no way to know shedding is happening. This invisible transmission is a major reason HSV-1 is so widespread.
How HSV-1 Testing Works
If you’ve never had a cold sore and are curious whether you carry HSV-1, a blood test can check for antibodies. These tests look for immune proteins your body produces after infection, not the virus itself. They can detect a past infection regardless of whether you’ve ever had symptoms.
The accuracy of these blood tests varies. A 2024 study comparing three widely used antibody tests against the gold-standard Western blot found that two of the tests had high specificity (over 97%, meaning very few false positives) but lower sensitivity (under 85%, meaning they miss some true infections). A third test caught more true infections (92% sensitivity) but produced more false positives, especially at low-positive index values, where over 60% of positive results turned out to be wrong. If you receive a low-positive result on a screening test, a confirmatory Western blot may be worth requesting.
Eye Complications Are Rare but Serious
HSV-1 occasionally reactivates in the nerve branch that serves the eye rather than the lip, causing a condition called herpes keratitis. Globally, an estimated 1.7 million people develop this each year, which works out to about 24 cases per 100,000 people. Most of these are superficial infections of the cornea’s outer layer, and vision usually stays intact if only that surface layer is affected (about 9% experience some vision impairment). When the infection reaches deeper layers of the cornea, the risk of vision loss jumps to 24 to 42%. An estimated 230,000 people per year develop new vision impairment in one eye from herpes keratitis. Recurrences in the same eye increase cumulative damage over time.